BIO-key Retained Earnings (Accumulated Deficit) 2010-2024 | BKYI
BIO-key retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
BIO-key Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
2024 |
$-129 |
2023 |
$-125 |
2022 |
$-116 |
2021 |
$-105 |
2020 |
$-100 |
2019 |
$-90 |
2018 |
$-75 |
2017 |
$-67 |
2016 |
$-63 |
2015 |
$-59 |
2014 |
$-57 |
2013 |
$-55 |
2012 |
$-52 |
2011 |
$-52 |
2010 |
$-50 |
2009 |
$-50 |
BIO-key Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
2024-12-31 |
$-129 |
2024-09-30 |
$-128 |
2024-06-30 |
$-127 |
2024-03-31 |
$-126 |
2023-12-31 |
$-125 |
2023-09-30 |
$-119 |
2023-06-30 |
$-118 |
2023-03-31 |
$-117 |
2022-12-31 |
$-116 |
2022-09-30 |
$-110 |
2022-06-30 |
$-107 |
2022-03-31 |
$-106 |
2021-12-31 |
$-105 |
2021-09-30 |
$-103 |
2021-06-30 |
$-102 |
2021-03-31 |
$-100 |
2020-12-31 |
$-100 |
2020-09-30 |
$-98 |
2020-06-30 |
$-95 |
2020-03-31 |
$-93 |
2019-12-31 |
$-90 |
2019-09-30 |
$-80 |
2019-06-30 |
$-78 |
2019-03-31 |
$-77 |
2018-12-31 |
$-75 |
2018-09-30 |
$-74 |
2018-06-30 |
$-71 |
2018-03-31 |
$-69 |
2017-12-31 |
$-67 |
2017-09-30 |
$-68 |
2017-06-30 |
$-66 |
2017-03-31 |
$-64 |
2016-12-31 |
$-63 |
2016-09-30 |
$-62 |
2016-06-30 |
$-61 |
2016-03-31 |
$-60 |
2015-12-31 |
$-59 |
2015-09-30 |
$-58 |
2015-06-30 |
$-57 |
2015-03-31 |
$-58 |
2014-12-31 |
$-57 |
2014-09-30 |
$-56 |
2014-06-30 |
$-56 |
2014-03-31 |
$-55 |
2013-12-31 |
$-55 |
2013-09-30 |
$-54 |
2013-06-30 |
$-53 |
2013-03-31 |
$-53 |
2012-12-31 |
$-52 |
2012-09-30 |
$-53 |
2012-06-30 |
$-53 |
2012-03-31 |
$-52 |
2011-12-31 |
$-52 |
2011-09-30 |
$-51 |
2011-06-30 |
$-51 |
2011-03-31 |
$-50 |
2010-12-31 |
$-50 |
2010-09-30 |
$-50 |
2010-06-30 |
$-49 |
2010-03-31 |
$-49 |
2009-12-31 |
$-50 |
2009-09-30 |
$-54 |
2009-06-30 |
$-54 |
2009-03-31 |
$-55 |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
ELEC PRODS-MISC |
$0.005B |
$0.007B |
BIO-key develops and licenses advanced biometric finger identification software products that are cost effective, scalable and easy to deploy. BIO-key's capabilities, such as preventing false identities through alias checks and hardware independence, are very unique to the biometric market place and represent a significant advancement over other biometrics. Product offerings are reflective of BIO-keys' leadership position in the biometric finger identification market and their commitment to the innovation of identification technology tools.
|